Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 7 studies | 25% ± 9% |
Insufficient scRNA-seq data for expression of PIAS3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3776.00 | 1445 / 1445 | 100% | 37.28 | 183 / 183 |
ovary | 100% | 3870.06 | 180 / 180 | 99% | 38.12 | 427 / 430 |
lung | 100% | 2921.19 | 578 / 578 | 99% | 37.17 | 1145 / 1155 |
breast | 100% | 3909.95 | 459 / 459 | 99% | 46.57 | 1104 / 1118 |
skin | 100% | 4446.41 | 1809 / 1809 | 98% | 25.76 | 462 / 472 |
uterus | 100% | 5202.59 | 170 / 170 | 97% | 40.09 | 443 / 459 |
pancreas | 98% | 1272.74 | 321 / 328 | 98% | 27.58 | 175 / 178 |
prostate | 100% | 3819.41 | 245 / 245 | 96% | 26.05 | 482 / 502 |
bladder | 100% | 4221.48 | 21 / 21 | 95% | 26.42 | 480 / 504 |
thymus | 100% | 2589.83 | 652 / 653 | 95% | 21.24 | 572 / 605 |
brain | 95% | 1531.87 | 2500 / 2642 | 99% | 21.76 | 698 / 705 |
intestine | 100% | 2903.37 | 965 / 966 | 92% | 15.32 | 484 / 527 |
stomach | 100% | 2666.88 | 359 / 359 | 91% | 17.11 | 260 / 286 |
kidney | 100% | 2005.72 | 89 / 89 | 87% | 14.32 | 784 / 901 |
adrenal gland | 99% | 1634.90 | 256 / 258 | 83% | 14.19 | 190 / 230 |
liver | 61% | 461.45 | 137 / 226 | 47% | 6.19 | 192 / 406 |
adipose | 100% | 2767.77 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 4662.73 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 2266.70 | 241 / 241 | 0% | 0 | 0 / 0 |
muscle | 99% | 1767.89 | 795 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 1562.20 | 851 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 34.69 | 44 / 45 |
eye | 0% | 0 | 0 / 0 | 79% | 8.21 | 63 / 80 |
peripheral blood | 66% | 663.43 | 611 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 62% | 8.78 | 18 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0045671 | Biological process | negative regulation of osteoclast differentiation |
GO_0016925 | Biological process | protein sumoylation |
GO_0033235 | Biological process | positive regulation of protein sumoylation |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0010803 | Biological process | regulation of tumor necrosis factor-mediated signaling pathway |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0033234 | Biological process | negative regulation of protein sumoylation |
GO_0016607 | Cellular component | nuclear speck |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005737 | Cellular component | cytoplasm |
GO_0019789 | Molecular function | SUMO transferase activity |
GO_0005515 | Molecular function | protein binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0003712 | Molecular function | transcription coregulator activity |
GO_0061665 | Molecular function | SUMO ligase activity |
Gene name | PIAS3 |
Protein name | PIAS3 protein (Protein inhibitor of activated STAT3) E3 SUMO-protein ligase PIAS3 (EC 2.3.2.-) (E3 SUMO-protein transferase PIAS3) (Protein inhibitor of activated STAT protein 3) Protein inhibitor of activated STAT, 3, isoform CRA_b Protein inhibitor of activated STAT 3 |
Synonyms | hCG_37029 DKFZp434O0617 |
Description | FUNCTION: Functions as an E3-type small ubiquitin-like modifier (SUMO) ligase, stabilizing the interaction between UBE2I and the substrate, and as a SUMO-tethering factor. Plays a crucial role as a transcriptional coregulation in various cellular pathways, including the STAT pathway and the steroid hormone signaling pathway. Involved in regulating STAT3 signaling via inhibiting STAT3 DNA-binding and suppressing cell growth. Enhances the sumoylation of MTA1 and may participate in its paralog-selective sumoylation . Sumoylates CCAR2 which promotes its interaction with SIRT1 . Diminishes the sumoylation of ZFHX3 by preventing the colocalization of ZFHX3 with SUMO1 in the nucleus . . |
Accessions | E9PHH8 U3KQV1 ENST00000393045.7 Q6IAR4 ENST00000393046.3 E7ESB4 ENST00000463514.2 ENST00000369298.5 Q9UFA8 Q9Y6X2 |